Advertisement
Advertisement
U.S. markets open in 5 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.09+4.01 (+10.81%)
At close: 04:00PM EDT
41.99 +0.90 (+2.19%)
Pre-Market: 04:00AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close37.08
Open36.79
Bid0.00 x 800
Ask0.00 x 800
Day's Range35.92 - 41.20
52 Week Range25.07 - 139.99
Volume1,406,153
Avg. Volume1,197,455
Market Cap2.312B
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-3.72
Earnings DateAug 04, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est46.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TWST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Twist Bioscience Corporation
    Analyst Report: Illumina IncIllumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions, government and commercial laboratories, and hospitals, as well as to pharmaceutical, biotech, agrigenomics, and consumer genomics businesses. The company's portfolio of products and services are designed to accelerate and simplify genetic analysis. The company also invests in startup companies that are pursuing promising genomic-related opportunities. It has roughly 9,100 full-time employees. ILMN shares are included in the S&P 500 index.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • Business Wire

    Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

    SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea, June 30, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop antibodies for applications in immuno-oncology.

  • Zacks

    Twist Bioscience (TWST) Stock Jumps 7.7%: Will It Continue to Soar?

    Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

  • Motley Fool

    3 Stocks That Could Double by 2025

    Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Twist Bioscience (NASDAQ: TWST). Prosper Junior Bakiny (Axsome Therapeutics): Investors intent on doubling their money by 2025 might benefit from looking at stocks that seem wildly undervalued and could experience multiple catalysts in the next couple of years. Axsome Therapeutics lagged the market in recent months, primarily because of regulatory roadblocks.

Advertisement
Advertisement